Change over period: —
NSE · TAKE
TAKE
-75.2% from the 52-week high · +22.6% above the low
TAKE Solutions Ltd. engages in the provision of end-to-end services and solutions in the domain of Life Sciences. The company is headquartered in Chennai, Tamil Nadu and currently employs 211 full-time employees. The company went IPO on 2007-08-27. The firm's segments include Life Sciences and Supply Chain Management. The company offers full-service clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance/safety services. Its services spans from clinical trials to regulatory submissions to post-marketing safety. The company provides services in life sciences sector across the spectrum of clinical, regulatory, safety and pharmacovigilance, networks and consulting to deliver end-to-end solutions and services across processes, technology and analytics to both domestic and global clients. The company also provides information technology (IT) infrastructure and support, engineering, designing and sourcing services. The firm operates in North America, Europe, Asia, and South America.
The short version. Return on equity was 35.0% in Mar 2026.
1 · The price
How has the stock traded?
TAKE trades 75.2% below its 52-week high and 22.6% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 net profit of ₹2 cr.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 29 | 30 | 54 | 1 | — | 0 | 2 | 9 |
| Net profit | 2 | 1 | 4 | 1 | 6 | -1 | -5 | 48 |
| Net margin % | 7.5 | 3.5 | 8.0 | 75.9 | — | -2219.5 | -287.7 | 559.4 |
| EPS (₹) | 0.15 | 0.07 | 0.29 | 0.07 | 0.43 | -0.06 | -0.33 | 3.22 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 54 | 10 | 66 | 189 | 655 | 774 | 2213 | 2039 |
| Net profit | 11 | 37 | -120 | -100 | -782 | -450 | -11 | 177 |
| Net margin % | 20.0 | 366.6 | -182.3 | -53.0 | -119.4 | -58.1 | -0.5 | 8.7 |
| EPS (₹) | 0.73 | 2.53 | -8.09 | -6.78 | -52.88 | -30.42 | -0.75 | 11.98 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 35.0% in Mar 2026; debt to equity is 0.00.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 35.0 | 182.5 | 1348.1 | -92.3 |
| Return on capital % | 15.4 | 13.2 | 10737.6 | -30.6 |
| EBITDA margin % | 7.8 | 26.9 | -156.4 | -10.6 |
| Net margin % | 17.8 | 366.6 | -178.1 | -50.8 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | -32.5% | -40.1% |
| Profit CAGR | — | — |
4 · The owners
Who holds it, and are they adding?
Up 0.21 pts over 8 quarters.
+0 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 53.41 | 53.41 | 53.34 | 5.19 | 0 | 0 | 0 | 0 | -53.41 |
| FII | 0 | 0 | 0 | 0 | 0.56 | 0.29 | 0.21 | 0.21 | +0.21 |
| DII | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 46.59 | 46.58 | 46.66 | 94.81 | 99.44 | 99.71 | 99.79 | 99.79 | +53.2 |
Mutual fund holdings · Oct 2026
2 schemes hold this stock
2 the month before.
- Motilal Oswal BSE Healthcare ETF0.01% of NAV
- Bandhan BSE Healthcare Index Fund0.01% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for TAKE are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Healthcare Services stocks
Quick answers
Common questions about TAKE
What is the TAKE share price?
TAKE (TAKE) last closed at ₹13.05, up 4.99% on the day. Its 52-week range is ₹10.14 to ₹50.14.
What is the market cap of TAKE?
TAKE has a market capitalisation of about ₹188 crore. Its price-to-earnings ratio is 18.0.
How are TAKE's latest results?
Return on equity was 35.0% in Mar 2026.
Who owns TAKE?
As of Sep 2026, shareholding was: FII 0.21%, Public 99.79%.
How many mutual funds hold TAKE?
2 mutual fund schemes held TAKE in October 2026. That compares with 2 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 01 Aug 2019 · Dividend - Rs. 0.4
- 22 Feb 2019 · Interim Dividend - Rs. 0.3
- 09 Nov 2018 · Interim Dividend - Rs. 0.3
- 02 Aug 2018 · Final Dividend - Rs. 0.4
- 02 Aug 2018 · Special Dividend - Rs. 0.6
- 15 Feb 2018 · Interim Dividend - Rs. 0.3
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.